Do Immediate Perioperative Glucose Measurements Predict Outcomes in Non-Elective Pedal Amputation?
- 25 February 2026
- journal article
- Published by SAGE Publications in Foot & Ankle Specialist
Abstract
Background: Approximately 20% of diabetic foot ulcers progress to amputation. While elevated glucose levels are known to increase infection risk in elective surgeries, their role in outcomes following non-elective amputation remains unclear. Methods. We conducted a 2-year retrospective chart review of adult patients who underwent non-elective, diabetes-related lower-extremity amputations at a tertiary care health system. Of 185 charts reviewed, 108 patients with at least 6 months of follow-up were included. Preoperative and immediate postoperative glucose values were recorded. Primary and secondary outcomes included healing time, postoperative infection, emergency department visits, and hospital readmissions. Multivariable regression models were used to adjust for patient sex, amputation level, and relevant comorbidities. Results: The mean healing time was 13.8 weeks (SD 12.9). Elevated perioperative glucose (>180 mg/dL) was associated with a 42% increase in healing time (P = .037). Postoperative infections occurred in 14.8% of patients and were associated with an almost two-fold increase in healing time (P=.001), as well as increased rates of emergency department visits and readmissions. Peripheral arterial disease and end-stage renal disease were independently associated with delayed healing and higher readmission rates. Conclusion: Elevated perioperative glucose levels, postoperative infection, peripheral arterial disease, and end-stage renal disease are associated with prolonged wound healing and higher complication rates after non-elective lower-extremity amputations in patients with diabetes. These findings underscore the importance of perioperative glucose optimization, infection prevention, and comprehensive management of comorbidities to improve surgical outcomes in this high-risk population.Keywords
Funding Information
- Division of Diabetes, Endocrinology, and Metabolic Diseases (K23DK131261)
- Division of Diabetes, Endocrinology, and Metabolic Diseases (K23DK131261-03S1)
- Division of Diabetes, Endocrinology, and Metabolic Diseases (P30DK020572)
- Division of Diabetes, Endocrinology, and Metabolic Diseases (U01DK119083)
This publication has 12 references indexed in Scilit:
- Management of Diabetes and Hyperglycemia in the Hospital: A Systematic Review of Clinical Practice GuidelinesDiabetes Care, 2025
- IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes‐related foot infections (IWGDF/IDSA 2023)Diabetes/Metabolism Research and Reviews, 2023
- Outcomes after minor lower limb amputation for peripheral arterial disease and diabetes: population-based cohort studyBritish Journal of Surgery, 2023
- The Effect of Elevated A1C on Immediate Postoperative Complications: A Prospective Observational StudyClinical Diabetes, 2018
- Diabetic Foot Ulcers and Their RecurrenceNew England Journal of Medicine, 2017
- American College of Foot and Ankle Surgeons® Clinical Consensus Statement: Perioperative ManagementThe Journal of Foot and Ankle Surgery, 2017
- The humanistic and economic burden of chronic wounds: a protocol for a systematic reviewSystematic Reviews, 2017
- Association Between Hemoglobin A1c and Surgical Morbidity in Elective Foot and Ankle SurgeryThe Journal of Foot and Ankle Surgery, 2016
- Perioperative Glycemic Control and the Effect on Surgical Site Infections in Diabetic Patients Undergoing Foot and Ankle SurgeryFoot & Ankle Specialist, 2015
- Supporting information retrieval from electronic health records: A report of University of Michigan’s nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE)Journal of Biomedical Informatics, 2015